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http://www.biomedcentral.com/1471-2407/14/927RESEARCH ARTICLE Open AccessMissed opportunities: racial and neighborhood
socioeconomic disparities in emergency
colorectal cancer diagnosis and surgery
Sandi L Pruitt1,2*, Nicholas O Davidson3,4, Samir Gupta5,6, Yan Yan4,7 and Mario Schootman8Abstract
Background: Disparities by race and neighborhood socioeconomic status exist for many colorectal cancer (CRC)
outcomes, including screening use and mortality. We used population-based data to determine if disparities also
exist for emergency CRC diagnosis and surgery.
Methods: We examined two emergency CRC outcomes using 1992–2005 population-based U.S. SEER-Medicare
data. Among CRC patients aged ≥66 years, we examined racial (African American vs. white) and neighborhood
poverty disparities in two emergency outcomes defined as: 1) newly diagnosed CRC or 2) CRC surgery associated
with: obstruction, perforation, or emergency inpatient admission. Multilevel logistic regression (patients nested in
census tracts) analyses adjusted for sociodemographic, tumor, and clinical covariates.
Results: Of 83,330 CRC patients, 29.1% were diagnosed emergently. Of 55,046 undergoing surgery, 26.0% had
emergency surgery. For both outcomes, race and neighborhood poverty disparities were evident. A significant race
by poverty interaction (p < .001) was noted: poverty rate was associated with both outcomes among African
Americans, but not whites. Compared to whites in low poverty (<10%) neighborhoods, African Americans in high
poverty (≥20%) neighborhoods had increased odds of emergency diagnosis (AOR: 1.50, 95% CI: 1.38-1.63) and
surgery (AOR: 1.63, 95% CI: 1.47-1.81).
Conclusions: Emergency CRC outcomes are associated with high poverty residence among African Americans
in this population-based study, potentially contributing to observed disparities in CRC morbidity and mortality.
Targeted efforts to increase CRC screening among African Americans living in high poverty neighborhoods could
reduce preventable disparities.
Keywords: Colorectal cancer, Emergency outcomes, Disparities, Race, Socioeconomic status, SEER-MedicareBackground
Colorectal cancer (CRC) screening results in dramatically
improved survival [1,2] and can prevent late-stage disease
and associated serious and emergent complications
including obstruction, perforation, hemorrhage, and
peritonitis. These complications, when presenting acutely,
are considered emergencies—posing immediate risks to
life or long-term impairment—and require immediate
intervention including surgical management and intensive
care unit stays. Of those diagnosed emergently and* Correspondence: Sandi.Pruitt@utsouthwestern.edu
1Department of Clinical Sciences, University of Texas Southwestern Medical
Center, 5323 Harry Hines Blvd E1, 410D Dallas, TX, USA
2Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA
Full list of author information is available at the end of the article
© 2014 Pruitt et al.; licensee BioMed Central. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.receiving curative resection, both short- and long-term
outcomes, including mortality and medical and surgical
complications, are significantly worse than those receiving
elective curative resection [3-5]. For example, a U.S.
National Inpatient Sample study demonstrated that emer-
gency resection was associated with a 3-fold increase of
in-hospital mortality, longer hospital stays, and greater
hospital costs [6]. Emergency resection is also associated
with suboptimal long-term outcomes. A U.S. Surveillance
Epidemiology and End Results (SEER)-Medicare study of
30,685 stage I-III colon cancer patients found that non-
elective resection was associated with significantly worse
five-year disease-specific survival (Hazard Ratio: 1.30,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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operative covariates [7].
CRC emergencies may disproportionately affect African
Americans and low socioeconomic status (SES) popula-
tions. For example, in a U.S. population-based study of
127,975 CRC patients undergoing resection in 2002,
African Americans were more likely to have emergency
resection [6]. However, in the same study, median income
of patients’ zip code was not associated with emergency
resection [6]. Studies from England and Canada, however,
demonstrate that CRC patients living in low SES neigh-
borhoods are more likely to be diagnosed emergently
[4,8,9]. African American and disadvantaged, low-SES
populations are less likely to have obtained and main-
tained cancer screening than their counterparts and partly
as a result, experience a disproportionate cancer burden
across numerous CRC outcomes [10-12]. For example,
compared to whites, African American men and women
have a 22-23% higher CRC incidence rate and a 46-53%
higher CRC mortality rate, respectively [13]. In a study
comparing those living in counties where <10% population
lived in poverty, both African Americans (OR: 1.13; 95% CI:
1.03-1.25) and whites (OR: 1.10; 95% CI: 1.06-1.15) living in
counties with ≥20% poverty had higher odds of distant
stage CRC [14].
The overwhelming majority of studies on emergency
diagnosis or surgery of CRC originate from Europe or
Canada, include small samples, and are not population-
based. Thus, the U.S. experience, particularly race and
SES disparities, has not been adequately studied. Further,
while there is documented geographic variation in CRC
outcomes such as screening and mortality, [15-20] the
extent of neighborhood variation in CRC emergencies is
unknown. Neighborhood variation indicates that shared
neighborhood-level characteristics, in addition to indi-
vidual characteristics, are associated with emergencies,
which could suggest a role for geographically-targeted
prevention strategies.
To our knowledge, there is only one population-based
U.S. study on emergency CRC diagnosis, [21] and none
that concurrently examine both emergency diagnosis
and surgery. Many patients diagnosed emergently have
advanced disease, multimorbidity, low functional status,
or poor prognosis, which could postpone or preclude
curative resection, particularly African Americans and
those of low SES who often present with more advanced
disease [14]. Thus, there is a paucity of information about
the distribution and correlates of emergency diagnosis
(with or without emergency curative resection) in the U.S.
Here we describe 1) variation across neighborhoods and
2) race and neighborhood SES disparities in two outcomes,
emergency CRC diagnosis and surgery, among U.S. CRC
patients aged ≥66 years. Given lower rates of screening and
worse CRC morbidity and mortality among AfricanAmericans [6,10,12,13] and patients in low SES neighbor-
hoods [4,8,9,14], we hypothesized these populations would
have higher rates of both emergency outcomes.Methods
Data sources
Data were obtained from an existing linkage of the
1992–2005 National Cancer Institute’s (NCI) SEER pro-
gram data with 1991–2006 Medicare claims files from the
Centers for Medicare and Medicaid. Data access was
granted by the NCI. As detailed elsewhere, [22] linked
SEER-Medicare data provide a rich source of information
on Medicare patients included in SEER, a nationally repre-
sentative collection of population-based cancer registries.
Ninety-four percent of cancer patients reported to SEER
aged 65 years or older have been successfully linked with
Medicare data [22]. Data for this study were available from
12 registries representing approximately 14% of the U.S.
population, [23] including states (Connecticut, Hawaii,
Iowa, New Mexico, and Utah), metropolitan areas (Atlanta,
Detroit, Los Angeles, San Francisco-Oakland, San Jose-
Monterey, and Seattle), and rural Georgia. This study was
reviewed by the Institutional Review Board at Washington
University and determined to be exempt from IRB
oversight.Study population
The study population included male and female patients
aged ≥66 with a diagnosis of a first primary invasive
colorectal cancer occurring from 1992 through 2005. We
included only those aged ≥66 to allow for one-year of
complete claims data pre-diagnosis to determine comor-
bidity. All patients had full coverage by both Medicare
Parts A and B from one year pre-diagnosis until 120 days
past primary surgery or until initiation of adjuvant chemo-
therapy, whichever came first. We excluded patients with
appendix cancer, only autopsy or death certificate records,
and members of HMOs. We excluded patients with a
diagnosis of Crohn’s disease, ulcerative colitis, inflamma-
tory bowel disease, or diverticulitis (ICD-9 556.X, 555.X,
562.01, 562.03, 562.11, 562.13) in the year prior to diagnosis.
Finally, we also excluded patients (n = 5,529) missing year
2000 census tract in the SEER-Medicare data.
For the emergency surgery analysis, we included only
patients with CRC surgeries (identified using ICD9 pro-
cedure codes described below) and excluded patients with
abdominal or pelvic postoperative adhesions (ICD-9
560.81, 568.0, 614.6) in the pre-surgery year due to a high
likelihood of emergency surgery for these conditions. We
further excluded patients with neoadjuvant chemotherapy
or radiation occurring in the year until 7 days before sur-
gery as an emergency in this situation could merely reflect
complications of a preexisting cancer [24].
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Emergency diagnosis and surgery
We defined emergency diagnosis and surgery as yes/no
variables by the presence of any of 3 emergency Medicare
claims indicators based on ICD9 codes and an inpatient
admission type indicator, including: 1) obstruction (560.89,
560.9); 2) perforation (569.83); or 3) emergency inpatient
admission (admtype = 1; patient required immediate med-
ical intervention as a result of severe, life threatening, or
potentially disabling conditions). These indicators were
identified from previous literature [6,7,9,24-26] and were
selected because they are highly correlated with CRC
emergencies; emergency surgeries are commonly a result
of obstruction and/or perforation [7]. Further, chosen indi-
cators are unlikely to identify nonemergent symptoms or
unrelated conditions (e.g. rectal bleeding is relatively non-
specific and could indicate minor bleeding or hemorrhoids).
For inclusion as an emergency outcome, we specified that
dates associated with the emergency indicators fall within
1) SEER month and year of initial CRC diagnosis (because
day of diagnosis is not available in SEER) (emergency diag-
nosis); or 2) within ±3 days of the first of any CRC surgery
(e.g. resections, pelvic exenteration, colostomy, [not includ-
ing colostomy reversals]) (emergency surgery).
Race and socioeconomic (SES) status
We compared non-Hispanic African Americans to non-
Hispanic whites. We defined SES as the percent of popu-
lation living in poverty in the patient’s residential census
tract at time of CRC diagnosis. We selected this indicator
because census tract-level poverty rate is a robust indica-
tor of SES, is associated with a variety of health outcomes
in diverse populations and across time, and has relevance
for policymakers [27,28]. We used 2000 U.S. Census data
using the following commonly used categories: <9.9%,
10–19.9%, and ≥20% [29,30].
Covariates
Multiple covariates associated with emergency CRC out-
comes in earlier studies [6,7,9,21] were examined. Covari-
ates obtained from SEER data included: year of diagnosis,
age (66–69, 70–74, 75–79, 80–84, ≥85), sex, SEER historic
stage (localized, regional, distant), tumor location (right
[cecum: 18.0, ascending colon: 18.2, hepatic flexure of
colon: 18.3, and transverse colon: 18.4] vs. left [splenic
flexure of colon: 18.5, descending colon: 18.6, sigmoid
colon: 18.7, rectosigmoid: 19.9, rectum: 20.9]), histology
(mucinous adenocarcinoma/signet ring cell, other adeno-
carcinoma, other, unknown), and tumor grade (low [well/
moderately differentiated] or high [poorly differentiated/
undifferentiated/anaplastic] or unknown).
Covariates obtained from Medicare claims included:
prior hospitalizations, comorbidity, preventable hospitaliza-
tions, number of endoscopies, and Medicaid and Medicare(“dual eligibility”). Prior hospitalizations occurring between
12–1 months prior to diagnosis were measured as yes/no.
To measure comorbidity, we searched inpatient or carrier
claims for multiple chronic conditions (e.g. myocardial in-
farction, diabetes, dementia, or AIDS) occurring between
12–1 months pre-diagnosis using Charlson comorbidity
index-Klabunde adaptation [31,32]. We further classified
comorbidity as none, one, or two or more following com-
mon practice. Preventable hospitalizations identify poor
ambulatory health care outcomes and can represent a
breakdown in access to or processes of primary care.
Following methods described elsewhere, [33] we searched
one-year pre-diagnosis of inpatient claims for potentially
preventable hospitalizations, including asthma, diabetes,
hypertension, pneumonia, and compared those with one
or more preventable hospitalizations to those with none.
Because claims provide accurate information on endoscopy
procedures but are less reliable for stool blood testing and
cannot distinguish screening from diagnostic tests, [34] we
measured total number of endoscopies (colonoscopies and
sigmoidoscopies) in the pre-diagnosis year, but were not
able to control for complete CRC screening history starting
at age 50. Dual-eligibility was defined as Medicaid eligibility
for at least 1 month during the pre-diagnosis year.
Census-tract urban/rural status (metropolitan, micropoli-
tan, or rural) was measured using 2000 Census Rural
Urban Continuum Area codes [35].
Statistical analysis
We describe sample characteristics and frequency of emer-
gency diagnosis and emergency surgery using descriptive
and chi-square statistics. We examine associations of race
and neighborhood poverty rate, including a race by poverty
interaction term, with both outcomes. We present 6
models: 1) empty model; 2) unadjusted race model; 3) un-
adjusted poverty model; 4) unadjusted race and poverty
model; 5) adjusted race and poverty main effects model;
and 6) adjusted race and poverty interaction model. Empty
models include no predictor variables, but include a hier-
archical structure, and are fit for the purpose of quantifying
variation (random effects) at the census tract level. We
multiplied race and poverty rate variables to determine if
an interaction was present on a synergistic scale and
retained the main effects of race and poverty in the model.
Covariates were retained if they were associated with out-
comes in bivariate analyses (p < .05). All models were fit
using multilevel logistic regression to account for nesting
of patients within residential census tracts, using SAS
PROC GLIMMIX (SAS Institute Inc, Cary, NC).
To facilitate interpretation of census-tract (“neighbor-
hood”) level random effects, we present variance and
standard error and Median Odds Ratio (MOR). The MOR
quantifies unexplained cluster heterogeneity [36,37] on a
scale directly comparable to odds ratios associated with
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effects variance component (V) from the regression model:
MOR ¼ exp 0:95 ffiffiffiffiVp . It is interpreted as the median
value of the ratio of predicted odds of the outcome for two
patients with equivalent covariates randomly chosen from
two different neighborhoods. MOR is always ≥1; 1.0 indi-
cates no variation between neighborhoods and larger
values indicate greater geographic variation.
In a sensitivity analysis, we disaggregated each emer-
gency outcome into 2 component variables (emergencies
defined as obstruction and/or perforation [because only
1.1% and 1.2% of all diagnoses and surgeries, respectively,
were associated with perforations] and emergency admis-
sion type [admtype = 1]) and re-fit all multilevel logistic
regression models separately for each outcome.
Results
Of all 83,330 eligible patients, 29.1% had an emergency
diagnosis. Of all patients undergoing surgery (n = 55,046),
26.0% had an emergency surgery. Table 1 presents sample
characteristics by presence of emergency diagnosis and
surgery status. All but one of the sample characteristics
differed (p < .001) by emergency status and were included
in the adjusted models. Occurrence of emergency diagno-
sis and emergency surgery did not significantly change
over time (p > .05); therefore year of diagnosis was not
included in the adjusted models. Of patients diagnosed
emergently and undergoing surgery, 84.0% had emergency
surgery. Of patients undergoing emergency surgery, nearly
all (94.0%) were also classified as having an emergency
diagnosis (data not shown).
Emergency diagnosis
Table 2 presents results from unadjusted and adjusted
multilevel analyses. Patients in the diagnosis sample
(n = 83,330) were nested within 14,191 census tracts
(range: 1–87 patients per tract). In all unadjusted and
adjusted main effects models, emergency diagnosis was
more likely for African Americans compared to whites,
and those living in the highest poverty census tracts, com-
pared to those in the lowest poverty census tracts. In the
adjusted main effects model (Model 5), African Americans
(vs. whites) (OR 1.28 [95% CI: 1.20-1.37]) and those living
in census tracts with the highest poverty rates (≥20%
vs. <10%) (OR 1.11 [95% CI: 1.04-1.18]) were more likely
to have emergency diagnosis.
Emergency surgery
Patients in the surgery sample (n = 55,046) were nested
within 12,886 census tracts (range: 1–66 patients per tract).
In all unadjusted and adjusted main effects models, African
Americans, compared to whites, and those living in the
highest poverty census tracts, compared to those in thelowest poverty tracts, were more likely to have emergency
surgery. In the adjusted main effects model (Model 5),
African Americans (vs. whites OR: 1.33 [95% CI: 1.23-
1.44]) and those living in the highest poverty census tracts
(≥20% vs. <10% poverty: OR: 1.11 [95% CI: 1.04-1.19]) were
more likely to have emergency surgery.
Race by neighborhood poverty interactions for
emergency diagnosis and surgery
Race by neighborhood poverty interactions (p < .001) were
evident for both outcomes in the final adjusted interaction
models (Model 6). Table 3 presents the number of patients
and the percent with both outcomes by group as well as
the adjusted race and poverty interaction effects. In the
interaction models, neighborhood poverty was no longer
associated with either outcome among whites. African
Americans living in the lowest poverty neighborhoods were
equally likely to have emergency outcomes as whites living
in similar conditions. Compared to whites in the lowest
poverty neighborhoods (<10%), African Americans living
in neighborhoods with ≥10% poverty rate demonstrated
higher odds of both outcomes. African Americans living in
the highest poverty neighborhoods (≥20%) had the greatest
odds of both emergency diagnosis (AOR: 1.50, 95% CI:
1.38-1.63) and surgery (AOR: 1.63, 95% CI: 1.47-1.81).
Neighborhood variation
Statistically significant variability in emergency diagnosis
was present across census tracts for both outcomes in all
models (Tables 2 and 3). In empty models (including no
predictor variables), the MOR for census-tract variability
in emergency diagnosis was 1.87. This can be interpreted
as follows: if a patient switched from living in a randomly
selected tract with low emergency diagnosis rate to ran-
domly selected tract with a higher emergency diagnosis
rate, her odds of emergency diagnosis would be 1.87 times
higher (in the median). Neighborhood variability in emer-
gency surgery (MOR= 1.97) was of similar magnitude.
Neighborhood variability persisted, with similar magni-
tude, in multivariable models, suggesting that none of the
covariates, including census tract poverty rate, accounted
for census-tract variability in either outcome.
In sensitivity analyses, we examined, separately, two dif-
ferent indicators of both emergency diagnosis and surgery
(data not shown). For both outcomes, in all models,
African Americans and those living in higher poverty
neighborhoods had higher odds of both 1) obstruction
and/or perforations; and 2) emergency admissions (p < .001
for all comparisons).
Discussion
To our knowledge this is the first U.S. population-based
study to demonstrate neighborhood variation and race
and SES disparities in both emergency CRC diagnosis and
Table 1 Sample characteristics of colorectal cancer patients, by emergency diagnosis and emergency surgery status
Diagnosis (n = 83,330)a Surgery (n = 55,046)a
Characteristic No emergency
diagnosis (n = 59,082)
Emergency
diagnosis (n = 24,248)
p (Chi2) No emergency
surgery (n = 40,740)
Emergency
surgery (n = 14,306)
p (Chi2)
n % n % n % n %
Race
White 54527 71.90 21313 28.10 <.0001 37957 75.01 12643 24.99 <.0001
African American 4555 60.81 2935 39.19 2783 62.60 1663 37.40
Neighborhood poverty rate
<10% 35999 71.72 14198 28.28 <.0001 25254 74.81 8505 25.19 <.0001
10-19.9% 14902 71.98 5801 28.02 10170 75.09 3374 24.91
≥20% 8181 65.82 4249 34.18 5316 68.66 2427 31.34
Sex
Male 27154 73.36 9860 26.64 <.0001 18215 75.71 5843 24.29 <.0001
Female 31928 68.94 14388 31.06 22525 72.69 8463 27.31
Age (mean [SD]) 77.2 7.1 79.6 7.6 <.0001 76.8 6.8 78.9 7.4 <.0001
Year
1992-1996 24621 70.68 10214 29.32 0.4126 9311 74.05 3263 25.95 0.9327
1997-2001 13092 71.21 5292 28.79 14847 74.08 5195 25.92
2002-2005 21369 70.97 8742 29.03 16582 73.93 5848 26.07
Medicaid enrollee
No 52170 72.54 19753 27.46 <.0001 36395 75.51 11802 24.49 <.0001
Yes 6912 60.59 4495 39.41 4345 63.44 2504 36.56
Rural urban commuting area
Metropolitan 46093 69.38 20346 30.62 <.0001 31657 72.45 12037 27.55 <.0001
Micropolitan 5246 76.23 1636 23.77 3595 78.91 961 21.09
Rural 7743 77.36 2266 22.64 5488 80.75 1308 19.25
Stage
Local 25470 78.60 6936 21.40 <.0001 17622 79.48 4549 20.52 <.0001
Regional 20160 69.12 9006 30.88 16936 72.69 6363 27.31
Distant 9840 60.94 6307 39.06 5436 64.66 2971 35.34
Tumor location
Left 31557 73.93 11127 26.07 <.0001 20204 75.47 6568 24.53 <.0001
Right 25162 68.09 11790 31.91 19953 73.04 7366 26.96
Tumor Grade
Low 40222 72.40 15337 27.60 <.0001 30066 75.09 9976 24.91 <.0001
High 10551 68.11 4941 31.89 8134 72.08 3150 27.92
Histology
Other adenocarcinoma 49541 71.73 19526 28.27 <.0001 35208 74.46 12078 25.54 <.0001
Mucinous
adenocarcinoma/signet
ring cell
6252 68.95 2816 31.05 4920 73.01 1819 26.99
Other 2365 64.09 1325 35.91 544 61.40 342 38.60
Comorbidity
0 34535 73.76 12284 26.24 <.0001 24359 76.19 7613 23.81 <.0001
1 14000 69.73 6077 30.27 9889 73.86 3500 26.14
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Table 1 Sample characteristics of colorectal cancer patients, by emergency diagnosis and emergency surgery status
(Continued)
≥2 9628 62.06 5887 37.94 6492 67.03 3193 32.97
Preventable hospitalization
No 55900 72.62 21077 27.38 <.0001 38522 75.20 12704 24.80 <.0001
Yes 3182 50.09 3171 49.91 2218 58.06 1602 41.94
Prior hospitalization <.0001
No 38866 82.62 8178 17.38 23910 82.93 4920 17.07
Yes 20216 55.71 16070 44.29 16830 64.20 9386 35.80
Endoscopies/prior year
None 32028 67.93 15118 32.07 <.0001 19435 69.11 8685 30.89 <.0001
1 16806 75.27 5521 24.73 13345 80.29 3277 19.71
≥2 10248 73.96 3609 26.04 7960 77.25 2344 22.75
aNumbers may not add up to total due to missing data.
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for a diverse array of socioeconomic, clinical, and tumor
covariates. Among the strengths of this study is that we
utilized multilevel models to demonstrate neighborhood
variation in emergency CRC diagnosis and surgery.
Observed disparities and neighborhood variation in
CRC emergencies indicate that breakdowns are occurring
across the CRC diagnosis and treatment continuum that
are systematically influenced by race, poverty, and/or
neighborhood. Conceptual models of the CRC diagnosis
and treatment continuum provide a framework for under-
standing where these break-downs are occurring. For
example, the CRC screening process continuum delineates
transitions from risk assessment to screening, detection,
diagnosis, and treatment for asymptomatic patients
undergoing CRC screening [39]. Likewise, for symptom-
atic CRC patients, The Aarhus statement [40] reviews
models [41,42] that describe the events and time intervals
leading from CRC symptom appraisal and detection to
diagnosis and treatment. There may be multiple identifi-
able break-down points across these continuums contrib-
uting to suboptimal screening uptake or delayed diagnosis
and/or treatment, thus leading to CRC emergencies. Fu-
ture interventions designed to prevent CRC emergencies
and eliminate disparities will need to explicitly acknow-
ledge the role of race, SES, and neighborhood influences
throughout the CRC continuum.
Race and SES disparities evident in our study have been
observed in some but not all previous U.S. studies, and no
studies to our knowledge have tested whether neighbor-
hood poverty affects emergency outcomes in African
Americans and whites equally. Previous large, multi-state
U.S. studies have demonstrated that African Americans
face higher risk of emergency resection [6,7]. In one of
these same studies, however, zip code median income was
not associated with emergency resection [6]. In another
study from Michigan, African American race and lowercensus tract median annual household income were asso-
ciated with increased odds of emergency CRC diagnosis in
bivariate but not in multivariate analyses [21]. Differences
in study design, populations, and case ascertainment may
explain these divergent findings. For example, the Michigan
study did not measure the urgency/emergency of the CRC
diagnosis itself, but classified patients as to whether they
had an ED visit within the month of or month before CRC
diagnosis [21]. Further, other studies used zip code- or cen-
sus tract- level median income, whereas we used a measure
of census tract poverty rate with a priori cut-points that
allow for nonlinear trends, as recommended by Krieger
et al. [27,43,44].
There are several possible explanations for the interactive
effects of race and neighborhood poverty we observed.
African American and disadvantaged, low-SES populations
are less likely to have obtained and maintained cancer
screening than their counterparts [10-12]. They also may
delay seeking care or experience health system delays once
engaged in the healthcare system. These populations are
less likely to have a regular primary care physician and
have reduced access to care [45-47]. However, emerging
evidence suggests that insurance and access to care alone
do not entirely explain observed disparities [48,49]. Even in
a study of Medicare beneficiaries with a usual physician,
rates of recent CRC screening were considerably lower
among patients with low SES [49,50]. Other factors such as
patient-physician communication, discrimination in health
care, logistical challenges such as transportation, the ability
to take time off of work, and capacity to navigate health
system bureaucracies may also play a role. The race by
poverty interaction (p < .001) whereby poverty rate was
associated with both outcomes only among African
Americans suggests that African Americans in high
poverty neighborhoods face additional, substantial bar-
riers to CRC screening and/or timely diagnosis. More
research is needed to better understand the dual effects
Table 2 The unadjusted and adjusted main effects between race and neighborhood poverty rate on emergency
diagnosis and emergency surgery and neighborhood random effects
Emergency diagnosis (n = 83,330 patients, 14,191 census tracts)
Characteristic Model 1
emptya model
Model 2 unadjusted
race model
Model 3 unadjusted
poverty model
Model 4 unadjusted
race and poverty model
Model 5 adjustedb race and
poverty main effects model
Odds ratios and 95% confidence intervals
Race
White - 1 - 1 1
African American - 1.58 1.50-1.67 - 1.48 1.40-1.57 1.28 (1.20-1.37)
Neighborhood poverty
rate
<10% - - 1 1 1
10-19.9% - - 1.01 0.97-1.05 0.98 0.94-1.02 0.98 (1.04-1.18)
≥20% - 1.32 1.26-1.39 1.17 1.11-1.23 1.11 (1.04-1.18)
Neighborhood random effects
Variance (se) .4317 (.0114) .4073 (.0110) .4225 (.0112) .4061 (.0110) .4887 (.0157)
Median odds ratio 1.87 1.84 1.86 1.84 1.95
Emergency surgery (n = 55,046 patients, 12,886 census tracts)
Characteristic Model 1a Model 2 Model 3 Model 4 Model 5b
Odds ratios and 95% confidence intervals
Race
White - 1 - 1 1
African American - 1.74 1.63-1.87 - 1.63 1.51-1.76 1.33 1.23-1.44
Neighborhood poverty
rate
<10% - - 1 1 1
10-19.9% - - 1.01 0.96-1.06 0.97 0.92-1.02 0.98 0.92-1.03
≥20% - - 1.36 1.28-1.45 1.17 1.10-1.25 1.11 1.04-1.19
Neighborhood random effects
Variance (se) .5086 (.0160) .4843 (.0155) .4994 (.0157) .4826 (.0154) .4410 (.0170)
Median odds ratio 1.97 1.94 1.96 1.94 1.88
aModel 1 is an empty model.
bModel 5 includes the following covariates: sex, urban/rural, Medicaid, comorbidity, prior hospitalization, preventable hospitalization, endoscopies in prior year,
stage, grade, histology, and tumor location.
Values in bold represent odds ratios for which the 95% confidence interval does not include the value one.
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CRC outcomes.
Notably, the neighborhood variability observed in our
study persisted even after controlling for all covariates,
including neighborhood poverty rate, indicating significant
unexplained neighborhood variation in both outcomes.
These results confirm a growing body of research suggest-
ing that CRC outcomes, including screening, incidence,
stage, and mortality, vary across geography [17,19,51-53].
For example, a prior study identified significant census-
tract level variation in CRC survival that remained unex-
plained after accounting for individual covariates and
neighborhood SES [19]. A more recent study identified
census tract level variation in CRC screening thatpersisted even after accounting for the impact of physician
and clinic- level influences using cross-classified statistical
models [53]. Observed geographic variations in CRC out-
comes remain poorly understood but may be a result of
many factors such as practice patterns, managed care
spillover, endoscopic capacity, or organizational culture
within and across health systems.
Our finding of race and neighborhood SES disparities
provides additional evidence of the disproportionate bur-
den of CRC morbidity and mortality borne by African
Americans and low-SES populations. CRC emergencies
result in both short-and long-term negative impacts on
morbidity, including postoperative complications, length
of hospital stay, hospital readmissions, treatment cost,
Table 3 Interaction between race and neighborhood poverty rate on emergency diagnosis and emergency surgery and
neighborhood random effects in adjusted race and poverty interaction models (Model 6)a
Emergency diagnosis Emergency surgery
Total Percent
emergencies
Odds ratios and 95%
confidence intervals
Total Percent
emergencies
Odds ratios and 95%
confidence intervals
White
<10% 48767 28.1 1 32922 25.0 1
10-19.9% 18903 27.3 0.97 0.92-1.02 12433 24.0 0.99 0.93-1.05
≥20% 8170 29.9 1.04 0.98-1.12 5245 26.8 1.06 0.98-1.15
Black
<10% 1430 33.9 1.09 0.95-1.25 837 31.1 1.09 0.92-1.30
10-19.9% 1800 35.8 1.16 1.02-1.31 1111 34.6 1.27 1.09-1.47
≥20% 4260 42.4 1.50 1.38-1.63 2498 40.8 1.63 1.47-1.81
Variance (se) .4881 (.0157) .6254 (.0221)
Median odds ratio 1.95 2.13
aModels adjusted for the following covariates: sex, urban/rural, Medicaid, comorbidity, prior hospitalization, preventable hospitalization, endoscopies in prior year,
stage, grade, histology, and tumor location, and the main effects of race and neighborhood poverty.
Values in bold represent odds ratios for which the 95% confidence interval does not include the value one.
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chosocial outcomes and quality of life. The higher num-
ber of CRC emergencies among African Americans in
high poverty neighborhoods may account for some of
the disproportionate burden in CRC morbidity and mor-
tality in these populations. Future research should exam-
ine interactions between race and poverty and should
explore the extent to which race and SES disparities in
emergency diagnosis account for observed disparities in
morbidity and mortality.
It is difficult to directly compare the rate of emergencies
we observed to other studies given different sampling
strategies, populations, time periods under study, and
methods of ascertaining CRC emergencies. Among 4
population-based U.S. studies, numbers range consider-
ably. A National Inpatient Sample study reported 10.6% of
CRC patients aged 65 and older had emergency resections
in 2002, defined as surgery in the presence of perforation,
peritonitis, or obstruction [6]. In Michigan, 23% of CRC
patients aged 66 years and older, diagnosed 1996–2000,
had emergency diagnoses [21]. Using a measure of in-
patient resection acuity, a SEER-Medicare study of Stage
I-III colon cancer patients diagnosed 1996–2003 found
that 40% of patients had urgent/emergent resections [7].
Another SEER-Medicare study of colon cancer patients
with adenocarcinoma diagnosed 1991–1996, found that
19.7% had emergent hospitalizations and 9.1% had ob-
struction or perforation [26]. This last study by Schrag
et al. used the same ICD9 codes as in the present study,
together with the same or similar Medicare claim code
for emergent hospital admission [26]. A validated and
widely used measure of emergent diagnoses and surger-
ies would facilitate comparisons across populations and
over time.Emergency colorectal cancer resection has been iden-
tified as “the clearest evidence on an individual level for
a failure of screening” [54]. Thus, CRC emergencies may
be an indicator to monitor progress in cancer screening
initiatives over time [4,24,57]. In the absence of CRC
screening, CRC emergencies may be the consequence
of delays occurring after symptom presentation [40].
Accordingly, monitoring CRC emergencies over time may
also provide insight into factors influencing diagnostic or
treatment delays, such as access to care. Notably, unlike a
Canadian study that documented a 24% relative decrease
(from 24-18%) in emergency CRC surgeries between
1993–2001, [24] we found no significant change in either
emergency outcome over time (p > .05). Given that an
average of 10–15 years elapse between adenomatous polyp
development and invasive cancer, [58,59] and that Medi-
care began covering some CRC screening modalities in
1998, adding colonoscopy for screening of average risk
adults in 2001, [60] it may be too soon to detect potential
downward trends in CRC emergencies. Given recent shifts
in economic and health policy trends, it is unclear
whether race and SES disparities in CRC emergencies will
persist, diminish, or potentially increase over time.
Our results should be interpreted in light of several limi-
tations. First, we include only Medicare-insured patients
aged 66 or older and therefore cannot generalize to youn-
ger or uninsured patients. Second, although we searched
claims for symptoms and codes indicating emergencies in
previous studies, [6,7,9,24-26] some misclassification may
have occurred. For example, we may have missed additional
emergencies indicated by rectal bleeding (the severity of
which cannot be measured with Medicare claims), in which
case true incidence may be higher. Last, while we measured
the number of lower endoscopies in the pre-diagnosis year,
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endoscopic procedure quality, nor could we distinguish be-
tween screening or diagnostic procedures.
Despite these limitations, our study has several advan-
tages over previous research. We conducted a multilevel
study using a large population-based sample of U.S.
CRC patients, used complete inpatient and outpatient
claim data, and were able to adjust for a diverse array of
tumor, patient, and neighborhood-level covariates. We
further provided the first evidence of neighborhood vari-
ation and race and SES disparities in both emergency
diagnosis and surgery.
Conclusions
We documented neighborhood, race and SES disparities
in CRC emergencies, where African Americans living in
high poverty neighborhoods have the highest odds of two
emergency outcomes and where significant neighborhood
variation remains unexplained. Targeted interventions to
increase screening in these vulnerable populations would
reduce these preventable disparities.
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